![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 17, 13852-13857, April 27, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Regulation of the stability of p53 is key to its
tumor-suppressing activities. mdm2 directly binds to the
amino-terminal region of p53 and targets it for degradation through the
ubiquitin-proteasome pathway. The coactivator protein
TAFII31 binds to p53 at the amino-terminal region that is
also required for interaction with mdm2. In this report, we demonstrate
that expression of TAFII31 inhibits mdm2-mediated ubiquitination of p53 and increases p53 levels.
TAFII31-mediated p53 stabilization results in activation of
p53-mediated transcriptional activity and leads to
p53-dependent growth arrest in fibroblasts. UV-induced
stabilization of p53 coincides with an increase in p53-associated
TAFII31 and a corresponding decrease in mdm2-p53 interaction. Non-p53 binding mutant of TAFII31 fails to
stabilize p53. Our results suggest that direct interaction of
TAFII31 and p53 not only mediates p53 transcriptional
activation but also protects p53 from mdm2-mediated degradation,
thereby resulting in activation of p53 functions.
Stabilization and Activation of p53 by the Coactivator Protein
TAFII31*
,
,
,
,
,
, and
Derald H. Ruttenberg Cancer Center, Mount
Sinai School of Medicine, New York, New York 10029, the
¶ Department of Biochemistry and Molecular Biology, Oregon Health
Sciences University, Portland, Oregon 97201, and the
§ Huffington Center on Aging and Department of Molecular and
Cellular Biology, Baylor College of Medicine,
Houston, Texas 77030
*
This work was supported by a NCI, National Institutes of
Health Grants P01 CA80058 (to Z. R. and X. W.), CA78419 (to
Z. R.), and CA 69161 (to J. J. M.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Supported by National Institutes of Health and American Cancer
Society funds.
**
To whom correspondence should be addressed: The Huffington Center
on Aging and Department of Molecular and Cellular Biology, Baylor
College of Medicine, Houston, TX 77030. E-mail: xiangwei@ bcm.tmc.edu.
This article has been cited by other articles:
![]() |
M. Rossi, O. N. Demidov, C. W. Anderson, E. Appella, and S. J. Mazur Induction of PPM1D following DNA-damaging treatments through a conserved p53 response element coincides with a shift in the use of transcription initiation sites Nucleic Acids Res., November 10, 2008; (2008) gkn888v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Batta and T. K. Kundu Activation of p53 Function by Human Transcriptional Coactivator PC4: Role of Protein-Protein Interaction, DNA Bending, and Posttranslational Modifications Mol. Cell. Biol., November 1, 2007; 27(21): 7603 - 7614. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Xu, X. Meng, Y. Cai, H. Liang, L. Nagarajan, and S. J. Brandt Single-stranded DNA-binding proteins regulate the abundance of LIM domain and LIM domain-binding proteins Genes & Dev., April 15, 2007; 21(8): 942 - 955. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. K. Melkoumian, X. Peng, B. Gan, X. Wu, and J.-L. Guan Mechanism of Cell Cycle Regulation by FIP200 in Human Breast Cancer Cells Cancer Res., August 1, 2005; 65(15): 6676 - 6684. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Frontini, E. Soutoglou, M. Argentini, C. Bole-Feysot, B. Jost, E. Scheer, and L. Tora TAF9b (Formerly TAF9L) Is a Bona Fide TAF That Has Unique and Overlapping Roles with TAF9 Mol. Cell. Biol., June 1, 2005; 25(11): 4638 - 4649. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Buss, A. Dorrie, M. L. Schmitz, E. Hoffmann, K. Resch, and M. Kracht Constitutive and Interleukin-1-inducible Phosphorylation of p65 NF-{kappa}B at Serine 536 Is Mediated by Multiple Protein Kinases Including I{kappa}B Kinase (IKK)-{alpha}, IKK{beta}, IKK{epsilon}, TRAF Family Member-associated (TANK)-binding Kinase 1 (TBK1), and an Unknown Kinase and Couples p65 to TATA-binding Protein-associated Factor II31-mediated Interleukin-8 Transcription J. Biol. Chem., December 31, 2004; 279(53): 55633 - 55643. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Banerjee, B. R. P. Kumar, and T. K. Kundu General Transcriptional Coactivator PC4 Activates p53 Function Mol. Cell. Biol., March 1, 2004; 24(5): 2052 - 2062. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Ard, C. Chatterjee, S. Kunjibettu, L. R. Adside, L. E. Gralinski, and S. B. McMahon Transcriptional Regulation of the mdm2 Oncogene by p53 Requires TRRAP Acetyltransferase Complexes Mol. Cell. Biol., August 15, 2002; 22(16): 5650 - 5661. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Alarcon-Vargas and Z.'e. Ronai p53-Mdm2--the affair that never ends Carcinogenesis, April 1, 2002; 23(4): 541 - 547. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |